SL Science Holding Ltd (SLBT) stock
SLBTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 18, 2026
$0.64−0.08 (-11.73%)
Close on Nov 17, 2026Market cap $356.14MP/E –Yield –
SL Science price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
No price to sales ratio figures for SL Science
SL Science has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?